uniQure Appoints SVP, Investor Relations And Communications
Gene therapy specialist uniQure N.V. has appointed Maria E. Cantor senior vice president, investor relations and communications. Cantor has over 20 years of communications experience in the biotech and healthcare industry, most recently at ARIAD Pharmaceuticals, where she was senior vice president, corporate affairs. Prior to this, she was senior director, corporate communications at Genzyme Inc., having previously held senior positions at the St. Elizabeth Medical Center in Boston, US, and at Optima Healthcare Inc.
Register for our free email digests: